EcoDrugPlus

B2 Bradykinin Receptor-Like

Ensembl ID : ENSORLG00000026974
Gene Symbol: LOC101161279
3 Cross references
243 Possible Orthologues:

Bcl2 Apoptosis Regulator

Ensembl ID : ENSORLG00000016791
Gene Symbol: BCL2
4 Cross references
176 Possible Orthologues:

Bcl2 Like 1

Ensembl ID : ENSORLG00000025151
Gene Symbol: BCL2L1
4 Cross references
226 Possible Orthologues:

Bcl2 Like 10

Ensembl ID : ENSORLG00000012758
Gene Symbol: BCL2L10
4 Cross references
128 Possible Orthologues:

Bcr Activator Of Rhogef And Gtpase

Ensembl ID : ENSORLG00000010674
Gene Symbol: BCR
4 Cross references
205 Possible Orthologues:

Bruton Tyrosine Kinase

Ensembl ID : ENSORLG00000000842
Gene Symbol: BTK
4 Cross references
204 Possible Orthologues:

C-C Chemokine Receptor Type 9

Ensembl ID : ENSORLG00000023168
Gene Symbol: LOC101157730
3 Cross references
188 Possible Orthologues:

C-C Motif Chemokine Receptor 9

Ensembl ID : ENSORLG00000027812
Gene Symbol: CCR9
4 Cross references
193 Possible Orthologues:

C-X-C Motif Chemokine Receptor 1

Ensembl ID : ENSORLG00000018075
Gene Symbol: CXCR1
4 Cross references
275 Possible Orthologues:

C-Reactive Protein

Ensembl ID : ENSORLG00000027565
Gene Symbol: LOC101165093
3 Cross references
400 Possible Orthologues:

C-Reactive Protein

Ensembl ID : ENSORLG00000030212
Gene Symbol: LOC101165585
3 Cross references
403 Possible Orthologues:

C-Reactive Protein

Ensembl ID : ENSORLG00000008394
Gene Symbol: LOC101165759
3 Cross references
402 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).